LYMPHANGIOLEIOMYOMATOSIS
Clinical trials for LYMPHANGIOLEIOMYOMATOSIS explained in plain language.
Never miss a new study
Get alerted when new LYMPHANGIOLEIOMYOMATOSIS trials appear
Sign up with your email to follow new studies for LYMPHANGIOLEIOMYOMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Leukemia drug tested for rare lung disease in new safety trial
Disease control Recruiting nowThis study is testing the long-term safety of a drug called imatinib in people with a rare lung disease called LAM. Imatinib is already approved for leukemia, and early research suggests it might kill LAM cells. The trial will enroll 20 women with LAM to take either imatinib or a…
Matched conditions: LYMPHANGIOLEIOMYOMATOSIS
Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Breathing breakthrough? study tests best way to deliver lung drug
Symptom relief Recruiting nowThis study aims to find out if a breathing medicine called albuterol works better for women with a rare lung disease (LAM) when given through a nebulizer machine versus a standard inhaler. Researchers will measure lung function in about 100 women over three days to see which meth…
Matched conditions: LYMPHANGIOLEIOMYOMATOSIS
Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
Tracking rare diseases in pregnancy to protect mothers and babies
Knowledge-focused Recruiting nowThis study is collecting information from pregnant women who have Tuberous Sclerosis Complex (TSC) or Lymphangioleiomyomatosis (LAM) to better understand how these conditions affect pregnancy. Participants complete monthly surveys about their health and medications during pregnan…
Matched conditions: LYMPHANGIOLEIOMYOMATOSIS
Sponsor: David M. Ritter • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Scientists hunt genetic clues to devastating Women's lung disease
Knowledge-focused Recruiting nowThis study aims to understand what causes Lymphangioleiomyomatosis (LAM), a rare and serious lung disease that mostly affects women. Researchers will study the genes and proteins in people with LAM to learn how the disease damages the lungs. The goal is to use this knowledge to d…
Matched conditions: LYMPHANGIOLEIOMYOMATOSIS
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC